Background Androgen deprivation therapy (ADT) for prostate cancer has numerous side
effects. Clinical guidelines for side effect management exist; however, these are not always …

Androgen deprivation therapy (ADT), a common treatment for prostate cancer, is associated
with physical, psychological, and sexual side effects that reduce patients' quality of life. The …

Background Androgen deprivation therapy (ADT) is associated with numerous toxicities that
are potentially modifiable. We sought to evaluate the impact of participation in a …

Background Evidence-based recommendations are available for the management of
androgen deprivation therapy (ADT)–induced side effects; however, there are no data on the …

Increasing numbers of men with non-metastatic disease are receiving androgen deprivation
therapy (ADT) for a variety of indications, some of which are supported by evidence from …

Context Androgen-deprivation therapy (ADT) is a key component of treatment for aggressive
and advanced prostate cancer, but it has also been associated with adverse effects on bone …

CONTEXT: Androgen deprivation therapy (ADT) is increasingly used for the treatment of
prostate cancer (PCa), even in clinical settings in which there is no evidence-based proof of …

Objective Androgen deprivation therapy (ADT) is the primary treatment for advanced
prostate cancer (CaP). There is growing evidence that ADT negatively affects men's …

The controversy over androgen deprivation therapy (ADT) for prostate cancer seems to have
shifted over the past decade. The issue of adverse events or side effects now seems to …

Improved diagnosis and treatment regimens have resulted in greater longevity for men with
prostate cancer. This has led to an increase in both androgen deprivation therapy (ADT) use …